startup specializing in precision medicine in oncology
MSInsight has raised €1.6M across 1 funding round from 5 investors, most recently a Seed round in Mar 2025. Based in Paris, France; active in Healthtech. Data as of 6 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-03-10 | Seed | €1.6M |
| Bpifrance,Calyseed,Capital Cell,Plateau de Saclay,Yes Invest |
| View deal → |
